American Journal of Kidney Diseases
Volume 56, Issue 4 , Pages 713-719 , October 2010

A Randomized Clinical Trial of Immunization With Combined Hepatitis A and B Versus Hepatitis B Alone for Hepatitis B Seroprotection in Hemodialysis Patients

  • Jennifer Tung, BScPhm

      Affiliations

    • St. Joseph's Healthcare, Hamilton, Ontario, Canada
    • ,
  • Euan Carlisle, MD

      Affiliations

    • McMaster University, Hamilton, Ontario, Canada
    • ,
  • Marek Smieja, MD, PhD

      Affiliations

    • McMaster University, Hamilton, Ontario, Canada
    • ,
  • Peter T. Kim, PhD

      Affiliations

    • Department of Math and Statistics, University of Guelph, Guelph, Ontario, Canada
    • ,
  • Christine H. Lee, MD

      Affiliations

    • McMaster University, Hamilton, Ontario, Canada
    • Corresponding Author InformationAddress correspondence to Christine H Lee, McMaster University, Hamilton, ON, Canada

Received 30 November 2009 ,Accepted 15 April 2010.

References 

  1. Murdoch DL, Goa K, Figgitt DP. Combined hepatitis A and B vaccines: a review of their immunogenicity and tolerability. Drugs. 2003;63(23):2625–2649
  2. Sherman M, Bain V, Villeneuve JP, et al. The management of chronic viral hepatitis: a Canadian consensus conference 2004. Can J Gastroenterol. 2004;18(12):715–728
  3. Zhang J, Zou S, Giulivi A. Hepatitis B in Canada. Canada Communicable Disease Report. 2001 Sept;10–1227S3
  4. Daniels D, Grytdal S, Wasley A Centers for Disease Control and Prevention (CDC). Surveillance for acute viral hepatitis—United States, 2007. MMWR Surveill Summ. 2009;58(3):1–27
  5. Hepatitis B Vaccine (Canadian Immunization Guide). Ottawa, Ontario: Public Health Agency of Canada Infectious Disease and Emergency Preparedness Branch Centre for Infectious Disease Prevention and Control under the authority of the Minister of Public Works and Government Services Canada; 2007;
  6. Rangel MC, Coronado VG, Euler GL, Strikas RA. Vaccine recommendations for patients on chronic dialysis. Semin Dial. 2000;13(2):101–107
  7. Stevens CE, Alter HJ, Taylor PE, Zang EA, Harley EJ, Szmuness W. Hepatitis B vaccine in patients receiving hemodialysis (Immunogenicity and efficacy). N Engl J Med. 1984;311(8):496–501
  8. Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR Recomm Rep. 2001;50(RR-5):1–43
  9. Bock M, Barros E, Veronese FJ. Hepatitis B vaccination in haemodialysis patients: a randomized clinical trial. Nephrology (Carlton). 2009;14(3):267–272
  10. Chow KM, Law MC, Leung CB, Szeto CC, Li PK. Antibody response to hepatitis B vaccine in end-stage renal disease patients. Nephron Clin Pract. 2006;103(3):c89–c93
  11. Tong NK, Beran J, Kee SA, et al. Immunogenicity and safety of an adjuvanted hepatitis B vaccine in pre-hemodialysis and hemodialysis patients. Kidney Int. 2005;68(5):2298–2303
  12. Kong NC, Beran J, Kee SA, et al. A new adjuvant improves the immune response to hepatitis B vaccine in hemodialysis patients. Kidney Int. 2008;73(7):856–862
  13. Mauri JM, Vallès M. Effects of recombinant interleukin-2 and revaccination for hepatitis B in previously vaccinated, non-responder, chronic uraemic patients (Collaborative Group of Girona). Nephrol Dial Transplant. 1997;12(4):729–732
  14. Ozener C, Fak AS, Avşar E, Cinar S, Lawrence R, Akoğlu E. The effect of alpha interferon therapy and short-interval intradermal administration on response to hepatitis B vaccine in haemodialysis patients. Nephrol Dial Transplant. 1999;14(5):1339–1340
  15. Miquilena-Colina ME, Lozano-Rodríguez T, García-Pozo L, et al. Recombinant interferon-alpha2b improves immune response to hepatitis B vaccination in haemodialysis patients: results of a randomised clinical trial. Vaccine. 2009;27(41):5654–5660
  16. Sali S, Alavian SM, Hajarizadeh B. Effect of levamisole supplementation on hepatitis B virus vaccination response in hemodialysis patients. Nephrology (Carlton). 2008;13(5):376–379
  17. Pérez-García R, Pérez-García A, Verbeelen D, Bernstein ED, Villarrubia VG, Alvarez-Mon M. AM3 (Inmunoferón) as an adjuvant to hepatitis B vaccination in hemodialysis patients. Kidney Int. 2002;61(5):1845–1852
  18. Barraclough KA, Wiggins KJ, Hawley CM, et al. Intradermal versus intramuscular hepatitis B vaccination in hemodialysis patients: a prospective open-label randomized controlled trial in nonresponders to primary vaccination. Am J Kidney Dis. 2009;54(1):95–103
  19. Fleischmann EH, Kruppenbacher J, Bock HL, Weber M. Active immunization against hepatitis A in dialysis patients. Nephrol Dial Transplant. 2002;17(10):1825–1828
  20. Ambrosch F, Wiedermann G, Andre FE, et al. Clinical and immunological investigation of a new combined hepatitis A and hepatitis B vaccine. J Med Virol. 1994;44(4):452–456
  21. Knoll A, Hottentrager B, Kainz J, Bretschneider BJilg W. Immunogenicity of a combined hepatitis A and B vaccine in healthy young adults. Vaccine. 2000;18(19):2029–2032
  22. Leroux-Roels G, Moreau W, Desombere I, Safary A. Safety and immunogenicity of a combined hepatitis A and hepatitis B vaccine in young healthy adults. Scand J Gastroenterol. 1996;31(10):1027–1031
  23. Czeschinski PA, Binding N, Witting U. Hepatitis A and hepatitis B vaccinations: immunogenicity of combined vaccine and of simultaneously or separately applied single vaccines. Vaccine. 2000;18(11-12):1074–1080
  24. Abraham B, Baine Y, De-Clercq N, et al. Magnitude and quality of antibody response to a combination hepatitis A and hepatitis B vaccine. Antiviral Res. 2002;53:63–73
  25. National Advisory Committee on Immunization. Canadian Immunization Guide. 6th ed.. Ottawa, Ontario, Canada: Canadian Medical Association; 2002;
  26. Engerix-B product monograph. GlaxoSmithKline; July 28, 2005;
  27. Pesanti E. Immunologic defects and vaccination in patients with chronic renal failure. Infect Dis Clin North Am. 2001;15(3):813–832
  28. Sezer S, Ozdemir FN, Güz G, et al. Factors influencing response to hepatitis B virus vaccination in hemodialysis patients. Transplant Proc. 2000;32:607–608
  29. Hepatitis B (HBV) vaccines (Abx Guide). http://www.hopkins-abxguide.org/Accessed April 23, 2008
  30. Mayor GH, Klein AM, Kelly TJ, Patterson MJ. Antibody to hepatitis A and hemodialysis. Am J Epidemiol. 1982;116(5):821–827

 Originally published online as doi:10.1053/j.ajkd.2010.04.015 on July 14, 2010.

 Trial registration: www.ClinicalTrials.gov; study number: NCT00186836

PII: S0272-6386(10)00912-1

doi: 10.1053/j.ajkd.2010.04.015

American Journal of Kidney Diseases
Volume 56, Issue 4 , Pages 713-719 , October 2010

Article Tools

* Image Usage & Resolution